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Edited by David LambethAbstract Proliferation of mesangial cells (MC) is an early
event in many forms of glomerulonephritis. We have previously
shown that platelet-derived growth factor (PDGF)-induced pro-
liferation of MC was inhibited by the overexpression of cycloox-
ygenase-2 (COX-2). Since reactive oxygen species (ROS) are
important mediators of mitogenic signaling, we evaluated the
role of ROS in the COX-2 induced growth arrest in MC. We
demonstrate that ROS are reduced in COX-2 overexpressing
MC. Intracellular elevation of ROS restored PDGF-induced
proliferation, while the expression of the cyclin-dependent kinase
inhibitors p21cip1 and p27kip1 were decreased in these cells. The
data suggest that COX-2 decreases ROS formation which con-
sequently leads to the PDGF-induced inhibition of MC prolifer-
ation.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Reactive oxygen species; Cyclooxygenase-2;
Mesangial cells; CDK inhibitors; PDGF; Proliferation; Cell
cycle1. Introduction
Proliferation of renal mesangial cells (MC) is an early event
in proliferative glomerulonephritis (GN) which may initiate
processes eventually leading to glomerulosclerosis [1]. In exper-
imental GN platelet-derived growth factor (PDGF) is an
important inducer of MC proliferation. Interfering with
PDGF ameliorates GN [2]. Enhanced generation of reactive
oxygen species (ROS) and their role as regulators of intracellu-
lar signaling in mitogenic pathways was also demonstrated in
human and experimental GN [3–6]. Brar et al. demonstrated
the requirement for ROS in PDGF-induced growth in airway
smooth muscle cells [7]. ROS which are generated directly in
response to PDGF seem to be important in the subsequent sig-
naling events leading to proliferation.Abbreviations: COX-2, cyclooxygenase-2; ROS, reactive oxygen spe-
cies; PDGF, platelet-derived growth factor; CDK, cyclin-dependent
kinase; COX-2+, cyclooxygenase overexpressing cell line; MC, mes-
angial cells; GN, glomerulonephritis
*Corresponding author. Fax: +49 40 42803 9036.
E-mail address: zahner@uke.uni-hamburg.de (G. Zahner).
0014-5793/$32.00  2006 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2006.03.063The rate-limiting enzymes in the formation of prostaglandins
are the cyclooxygenases [8]. Two cyclooxygenase isoforms are
currently known. Cyclooxygenase-1 (COX-1) is constitutively
expressed in many tissues and is responsible for the physiolog-
ical functions of prostaglandins. In contrast, cyclooxygenase-2
(COX-2) is an immediate early response gene which is rapidly
induced by proinﬂammatory cytokines and growth factors.
COX-2 gene expression is increased in diseases associated with
proliferation such as cancer and rheumatoid arthritis [9,10]. We
recently demonstrated, however, inhibition of PDGF-induced
proliferation of MC by stable overexpression of COX-2
through upregulation of the cyclin-dependent kinase (CDK)
inhibitors p21cip1 and p27kip1 [11].
Since MC directly generate ROS independently of inﬁltrating
cells [12], the present study examines the role of ROS in the
COX-2 mediated inhibition of PDGF-induced proliferation of
MC. In growth inhibited COX-2 overexpressing MC (COX-
2+MC), ROS concentration is decreased. Intracellular increase
of ROS through menadione abolished growth inhibition in
COX-2+ MC through downregulation of the CDK inhibitors
p21cip1 and p27kip1. This study suggests that a distinct ROS level
inMC is necessary for PDGF-induced proliferation and COX-2
seems to inﬂuence MC proliferation by triggering ROS.2. Materials and methods
2.1. Cell culture
Cell lines used in this study were characterized previously [11]. An
EcoRI/KpnI full length PCR construct of rat COX-2 was cloned into
the mammalian expression vector pcDNA3.1-Zeo (Invitrogen). For
transfection, 2 · 105 rat MC between passage 15–18 were seeded in
RPMI-1640 containing 10% FCS (Invitrogen). A mixture of 5 lg
COX-2 plasmid or empty pcDNA3.1-G418 plasmid for control cells
and 20 lg/ml Lipofectine (Life Technologies) in RPMI-1640 were
added to 70–80% conﬂuent MCs for 6 h at 37 C in 5% CO2. Cells were
maintained in RPMI-1640 containing 10% FCS for 48 h before selec-
tion was started by adding 200 lg/ml zeocin (Invitrogen) or 400 lg/
ml G418 (Invitrogen) for two weeks. Single cell clones of stable trans-
fected MCs were established further through limiting dilution, and
were cultured in 10% FCS RPMI-1640 supplemented with 100 lg/ml
zeocin (COX-2+ MC) or 200 lg/ml G418 at 37 C (VC-MC) in 5%
CO2. The two pcDNA3.1 vectors were used to avoid cross contamina-
tion of control (VC) and COX-2+ MCs.
2.2. Measurement of reactive O2
Reactive O2 measurement was performed through the ROS depen-
dent hydrolysis of CM-H2DCFDA (Molecular Probes) and subse-
quent ﬂuorescence detection. Serum-deprived conﬂuent COX-2+ andblished by Elsevier B.V. All rights reserved.
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with 5 lM menadione or 50 ng/ml PDGF for 1 h were supplemented
for the last 20 min with 2.5 lM H2DCFDA. Then the cells were tryp-
sinized and washed twice in PBS. H2DCFDA ﬂuorescence was deter-
mined by using 0.5 · 106 cells per ml in PBS with the FL1 channel
(excitation 488 nm; emission 515–545 nm) of a ﬂuorescence-activated
cell sorter calibur (Becton Dickinson).
2.3. Cell proliferation assay
Cells (5 · 103 cells/well) were plated on 96-well plates (Nunc) and
maintained in RPMI-1640 media supplemented with 10% FCS over
night. Subsequently, cells were incubated in serum free RPMI-1640
media for 24 h. DNA synthesis was measured by [3H] thymidine incor-
poration. 2 lCi/ml [3H] thymidine (90 Ci/mmol; Amersham Pharmacia
Biotech) was added to the serum free media for further 24 h. [3H] thy-
midine incorporation of the appropriate control group was compared
to cells that were additionally treated with 50 ng/ml rat PDGF-BB
(R&D Systems), 5 lM menadione or with the combination of 50 ng/
ml rat PDGF-BB and 5 lM menadione for 24 h. At the end of the
incubation period, cells were washed twice with 1 · PBS and were then
trypsinized. The cell suspensions were subsequently harvested onto a
ﬁlterpaper (Whatman) using an automated cell harvester (Dynatech)
before [3H] thymidine incorporation was measured in a b-scintillation
counter (Packard).
2.4. Cell counting
COX-2+ and control (VC) MC were seeded in 24-well plates (3 · 104
per well) and maintained in RPMI-1640 medium supplemented with
10% FCS over night. Subsequently, cells were incubated in serum free
RPMI-1640 media for 24 h. Cells in triplicate were treated either with
50 ng/ml PDGF-BB or 5 lM menadione alone or with the combina-
tion of 50 ng/ml rat PDGF-BB and 5 lM menadione for 24 h. At the
end of the incubation period, cells were washed twice with 1 · PBS
and were then trypsinized. Cells were resuspended in 100 ll serum free
RPMI-1640 media and subsequently counted in a Neubauer chamber.
2.5. Cell viability assay
Cell viability was measured by the CytoTox non-radioactive cyto-
toxicity assay obtained from Promega according to the manufacturer’s
recommendations.
2.6. Western blot analysis
Cells were washed with 1 · PBS and lysed in 1 · cell-lysis buﬀer
(150 mM Tris–HCl, pH 6.8, 6.6% SDS). Equal amounts of protein
were treated with 1/4 vol reducing buﬀer (50% mercaptoethanol, 50%
glycerol) as well as 1/5 vol gel loading buﬀer (42.5% glycerol, 0.05%
bromphenol blue), and samples were boiled for 10 min. The solution
was loaded onto a 12% polyacrylamide SDS gel and electrophoresed
at a constant current of 20 mA for 4 h. A molecular-weight marker
(14.3–220 kD, Amersham Pharmacia Biotech), was run in parallel.
After completion of electrophoresis, proteins were electroblotted semi-
dry (blotting buﬀer: 25 mM Tris, 200 mM glycine, 20% methanol) for
1 h at 1 mA/cm2 onto a PVDF membrane (Hybond ECL, Amersham
Pharmacia Biotech). The membrane was blocked in 5% non-fat dried
milk in washing buﬀer (1 · PBS, 0.1% Tween 20) for 1 h at room tem-
perature, then incubated for another hour with the primary antibody
in the same buﬀer. Both primary antibodies (anti human p27kip1, Cell
Signaling; anti human p21cip1, BD-Biosciences) were used at a dilution
of 1:1000. After rinsing the membrane in washing buﬀer for 2 · 10 min,
the p21cip1 blots were treated with an anti-mouse-IgG antibody conju-
gated to alkaline phosphatase (Southern Biotechnology) at a concen-
tration of 1:3500 for 1 h at room temperature. The p27kip1 blots
were treated with an anti-rabbit-IgG antibody conjugated to HRP
(Southern Biotechnology) under the same conditions. Detection of
the alkaline phosphatase activity was performed with CDP-Star (Tro-
pix) in assay buﬀer (10 mM Tris–HCl, pH 9.6, 150 mM NaCl, 50 mM
MgCl2) and detection of the HRP activity was performed with a highly
sensitive substrate (Visualizer, Upstate). Both substrate solutions
were used according to the manufacturer’s recommendations. Chemo-
luminescence detection of the blots as well as densitometric evaluation
were performed with the FluorS imager system (BioRad). Reincuba-
tion of the blots against b-actin (anti mouse b-actin 1:3000; Sigma)
were performed to account for small protein loading and transfer vari-
abilities.2.7. Statistical analysis
The data are presented as the means ± S.D. Statistical signiﬁcance
between diﬀerent groups was ﬁrst tested with the non-parametric
Kruskal–Wallis test. Individual groups were subsequently tested using
the Wilcoxon–Mann–Whitney test. A P value <0.05 was considered
signiﬁcant.3. Results
As demonstrated in Fig. 1A ROS concentrations in COX-
2+ MC are strongly decreased when compared to the mock-
transfected control (VC) MC. In Fig. 1B and C, the eﬀect of
menadione, a vitamin-K derivate that penetrates the cells
and intracellularly generates superoxide, on COX-2+ and con-
trol (VC) MC ROS levels were examined. To test, whether
menadione could increase cellular ROS levels, quiescent
COX-2+ and control (VC) MC were treated with 5 lM men-
adione for 1 h in serum free RPMI-1640 cell culture media.
Menadione strongly increases ROS levels of both cell-lines
compared to the appropriate cell-line cultured under serum
free conditions. To exclude potential toxic eﬀects of the ROS
donor menadione on the cell lines used, cell viability assays
were performed. Both cell lines show a viability of 80% when
cultivated in serum free RPMI-1640 media only and a viability
of 77% in the presence of 5 lM menadione. Therefore, the ef-
fects are unlikely due to menadione toxicity. Since PDGF in-
creases ROS levels in other cell systems [7,19] quiescent COX-
2+ and control (VC) MC were treated for 1 h with 50 ng/ml
PDGF to examine the eﬀect of PDGF one the ROS generation
in our cell culture system. Fig. 1D shows that PDGF did not
inﬂuence ROS levels of COX-2+ MC. In contrast, as demon-
strated in Fig. 1E, PDGF was capable of increasing ROS lev-
els in control (VC) MC.
Quiescent COX-2+ and control (VC) MC were treated with
50 ng/ml PDGF or 5 lM menadione and with a combination
of both substances in serum free RPMI-1640 media containing
2 lCi/ml [3H] thymidine. Fig. 2A depicts the [3H] thymidine
incorporation values of COX-2+ and control (VC) MC after
24 h. While PDGF (1.31 ± 0.15-fold) or menadione (1.29 ±
0.13-fold) hardly aﬀect cell proliferation of COX-2+ MC, the
combined administration of PDGFandmenadione signiﬁcantly
stimulate proliferation of this cell line 2.3 ± 0.25-fold (n = 3,
P < 0.05). In control (VC)MC, 50 ng/ml PDGFor the elevation
of the intracellular ROS levels through 5 lMmenadione stimu-
late proliferation 2.11 ± 0.19-fold and 1.79 ± 0.09-fold, respec-
tively. Both substances together additionally stimulate control
(VC) MC proliferation 2.6 ± 0.87.
For cell counting, quiescent COX-2+ and control (VC) MC
were treated again with 50 ng/ml PDGF or 5 lM menadione
and with a combination of both substances in serum free
RPMI-1640 media for 24 h. In Fig. 2B data from three inde-
pendent experiments are shown. According to the cell prolifer-
ation assays (Fig. 2A) in COX-2+ MC PDGF (1.03 ± 0.02)
and menadione (1.12 ± 0.07) hardly increased cell number of
COX-2+ cells. In contrast, the combination of 50 ng/ml PDGF
and 5 lM menadione increased cell number of COX-2+ MC
(1.57 ± 0.07) after 24 h when compared to COX-2+ MC culti-
vated under serum free conditions. Furthermore, again in
accordance to the cell proliferation assays (Fig. 2A) cell num-
bers of control (VC) MC showed comparable results. PDGF
(1.68 ± 0.06) and menadione (1.48 ± 0.04) increased cell num-
ber and the combination of PDGF and menadione resulted
Fig. 1. The ROS levels of control (VC) MC and COX-2+ MC (COX-2+) were measured by ROS dependent hydrolysis of CM-H2DCFDA and
subsequent quantiﬁcation of ﬂuorescence. (A) Control (VC) MC strongly generated higher amounts of ROS than COX-2+ MC. (B,C) COX-2+ and
control (VC) MC treated for 1 h with 5 lM menadione showed increased ROS generation compared to the appropriate cell-line in the absence of
menadione. (D) The addition of 50 ng/ml PDGF for 1 h did not inﬂuence ROS generation of COX-2+ MC. (E) PDGF (50 ng/ml) for 1 h increased
ROS generation of control (VC) MC. This graphs are representative for three independent experiments performed with qualitatively similar results.
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24 h when compared to the appropriate cell line cultivated un-
der serum free conditions.
To evaluate whether prostaglandins are responsible for the
cell growth eﬀects shown in Fig. 2, prostaglandin formation
was inhibited with the non-speciﬁc COX-inhibitor indometha-
cin (1 lg/ml) for 48 h. In the last 24 h, 50 ng/ml PDGF, 5 lM
menadione or a combination of both substances together with
2 lCi/ml [3H] thymidine were added to all samples. As demon-
strated in Fig. 3, neither PDGF (1.15 ± 0.3), menadione
(0.99 ± 0.14), nor the combination of both substances
(1.32 ± 0.32) signiﬁcantly inﬂuenced proliferation of COX-2+
MC compared to the appropriate indomethacin treated cell line.
Recently, we demonstrated that COX-2 overexpression
maintained gene expression of the CDK inhibitors p21cip1and p27kip1 in the presence of PDGF and thus inhibits cell pro-
liferation [11]. Since the intracellular increase of ROS restored
PDGF-induced proliferation in COX-2+ MC, we further elu-
cidated whether ROS inﬂuence protein expression of these
CDK inhibitors. For this purpose Western-blot analysis of
the CDK inhibitors p21cip1 and p27kip1 was performed. Quies-
cent COX-2+ and control (VC) MC were treated either with
50 ng/ml PDGF or 5 lMmenadione and with the combination
of both substances in serum free RPMI-1640 media for 1, 6
and 24 h. Protein expression of p21cip1 as well as p27kip1 was
measured and compared with the protein levels of the appro-
priate cell line cultivated in serum free RPMI-1640 medium.
As shown in Fig. 4, neither PDGF nor menadione alone signif-
icantly aﬀected the protein expression of p21cip1 and p27kip1 in
COX-2+ MC at all time points studied. In contrast, PDGF de-
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free control. (A) Results of [3H] thymidine incorporation. The
combined treatment of COX-2+ MC (COX-2+) with 5 lMmenadione
and 50 ng/ml PDGF signiﬁcantly increased [3H] thymidine incorpora-
tion when compared to the PDGF treatment alone (n = 3, P* < 0.05; *
vs. PDGF treatment). The treatment of either PDGF or menadione
alone as well as the combination of both substances signiﬁcantly
increased [3H] thymidine incorporation of control (VC) MC (n = 3,
P# < 0.05; vs. serum free control) whereas [3H] thymidine incorpora-
tion of COX-2+ MC hardly aﬀect cell proliferation compared to the
appropriate serum free control. (B) Results of the cell counts. In
accordance to the cell proliferation assay in Fig. 1A the combined
treatment of 5 lM menadione and 50 ng/ml PDGF signiﬁcantly
increased cell number in COX-2+ MC (n = 3, P* < 0.05; * vs. PDGF
treatment) compared to the appropriate PDGF treatment. Again, the
treatment of either PDGF or menadione alone as well as the
combination of both substances signiﬁcantly increased the cell
numbers of control (VC) MC (n = 3, P# < 0.05; # vs. serum free
control) whereas the cell numbers of COX-2+ MC almost remained
unaltered when compared to the appropriate serum free control.
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Fig. 3. Eﬀect of COX-2 inhibition on cell proliferation (n = 3). COX-2+
MCwere incubated for 48 h in serum free media in the presence of 1 lg/
ml indomethacin. In the last 24 h, 50 ng/ml PDGF, 5 lMmenadione or a
combination of both substances together with 2 lCi/ml [3H] thymidine
were added to all samples. The diﬀerent treatments were normalized to
indomethacin treated COX-2+MC.Neither PDGF,menadione nor the
combination of both substances signiﬁcantly inﬂuenced cell prolifera-
tion compared to indomethacin treated COX-2+ MC.
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(VC) MC after one and 6 h whereas menadione alone hardly
inﬂuenced p21cip1 and p27kip1 protein expression in this cell
line. The combination of both substances strongly decreased
protein expression of both CDK inhibitors after one and 6 h
in COX-2+ as well as control (VC) MC. Since one single dose
of 5 lM menadione was capable of increasing ROS levels in
COX-2+ and control (VC) MC about 6–8 h (data not shown)
and prolonged PDGF incubation leads to endogenous stimula-
tion of COX-2 which consequently increases both CDK inhib-
itors, after 24 h the protein expression of p21cip1 as well as of
p27kip1 was almost restored in both cell lines.4. Discussion
The proliferation of glomerular MC is a hallmark in immune
mediated renal diseases such as GN [1]. The formation of the
cyclooxygenase product prostaglandin E2 [14–17] as well as the
generation of ROS are enhanced in these diseases [3–6]. Since it
has been shown that in airway smooth muscle cells ROS are
required for PDGF-induced growth [7] and the overexpression
of COX-2 exerts antiproliferative eﬀects in glomerular MC [11]
which may counteract growth promoting events in glomerular
injury, the potential role of ROS in the COX-2 dependent cell
cycle arrest was examined in the current study.
The ROS concentrations of COX-2+ MC were decreased
when compared to control (VC) MC which implies a potential
COX-2 dependent inﬂuence on the cellular redox system either
by downregulation of the NADPH oxidase complex, which is
the major source of intracellular ROS and could inﬂuence cell
cyle regulation [22], and/or upregulation of enzymes such as
SOD and GPX which are capable to metabolize ROS in
H2O and O2. Moreover, catalase and NADPH oxidase could
probably be inﬂuenced by COX-2 because increased catalase
activity blocked PDGF-induced processes [19] and NADPH
oxidase plays a crucial role in PDGF-induced proliferation
in other cell systems [23].
Since PDGF increases the generation of ROS [19] and in our
control (VC) MC but not in COX-2+ MC (Fig. 1D, E), COX-2
seems to prevent the PDGF-induced ROS generation and thus
inhibits the mitogenic signal normally induced through PDGF.
Moreover, exogenous administration of the ROS donor mena-
dione increases intracellular ROS concentration in COX-2+
and control (VC)MCbut replaced PDGF-induced proliferation
only in control (VC)MC (Fig. 2). Thus, beside the eﬀects on the
cellular redox system, COX-2 seems to interfere with multiple
cellular signaling pathways. This may include the phosphatidyl-
inositol 3-kinase pathway which could mediate PDGF-induced
ROS production [21] as well as ROS dependent downstream sig-
naling pathways such as the erk1/2 MAP-kinase pathway
[13,18]. The COX-2 induced growth inhibition could only be re-
stored if PDGF and menadione were given in combination to
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Fig. 4. Western blot for the CDK inhibitors p21cip1 (A) and p27kip1 (B) of COX-2+ and control (VC) MC. PDGF (50 ng/ml) decreased protein
expression of both CDK inhibitors in control (VC) MC after one and 6 h but did not signiﬁcantly inﬂuence these protein levels in COX-2+ MC. The
combined treatment with 5 lMmenadione and 50 ng/ml PDGF strongly decreased protein expression of the CDK inhibitors for one and 6 h in both
cell lines. After 24 h the protein expression of p21cip1 and p27kip1 are almost restored in both cell lines. These blots are representative for three
independent experiments performed with qualitatively similar results.
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ence of COX-2 leading to PDGF-induced cell proliferation. It
seems that a distinct amount of intracellular available ROS are
necessary to bypass the COX-2 inhibited cellular signaling path-
ways through PDGF in COX-2+ MC.
Since prostaglandins are known to inﬂuence MC prolifera-
tion [25] the potential role of these cyclooxygenase products
on ROS dependent cell proliferation in COX-2+ MC were
examined. COX-2+ MC were treated with the non-speciﬁc
COX inhibitor indomethacin (1 lg/ml) for 48 h. Although
1 lg/ml indomethacin almost completely inhibits COX activity
in COX-2+ MC [11] neither PDGF or menadione nor the com-
bination of both are capable of signiﬁcantly inducing prolifer-
ation. This observation is in accordance with earlier studies of
others [26] and ourselves [11] which showed almost no inﬂu-
ence of COX inhibition in cells stable overexpressing COX-2.
Interestingly, ROS and PDGF require almost 24 h to bypass
the COX-2 induced cell cycle arrest (Fig. 2), which supposesindirect mechanisms probably through inﬂuencing factors like
CDK inhibitors of the kip/cip family in the G1 phase of the cell
cycle. Recently, we have demonstrated the importance of the
CDK inhibitors p21cip1 and p27kip1 in the COX-2 dependent
cell cycle arrest [11] and others have demonstrated that oxida-
tive stress could inﬂuence p21cip1 degradation in cystric ﬁbrosis
lung epithelial cells [24]. Therefore, we examined the possible
inﬂuence of ROS on the protein expression of both CDK
inhibitors. In the presence of menadione PDGF strongly de-
creased protein expression of p21cip1 as well as p27kip1 in
COX-2+ MC within 1 h when compared to the same cell line
in the absence of a ROS donor. Again, the elevation of the
intracellular ROS levels due to the menadione administration
in COX-2+ MC in combination with PDGF prevents the
COX-2 dependent stabilization of p21cip1 and p27kip1 begin-
ning within 1 h which consequently leads to proliferation of
COX-2+ MC after 24 h. This fast downregulation of both
CDK inhibitors further supports the participation of post-
2528 G. Zahner et al. / FEBS Letters 580 (2006) 2523–2528translational protein modiﬁcations in cellular signaling
pathways rather than events leading to new protein synthesis.
Phosphorylation, for example, of protein kinases within the
phosphatidylinositol 3-kinase and/or erk1/2 MAP-kinase path-
ways in response to PDGF and menadione could be responsi-
ble for the fast degradation of p21cip1 and p27kip1. 24 h after
PDGF and menadione administration the protein expression
of both CDK inhibitors is almost restored. This eﬀect was ex-
pected since one single dose of 5 lMmenadione was capable of
increasing ROS levels in COX-2+ and control (VC) MC about
6–8 h (data not shown). Furthermore, prolonged PDGF incu-
bation leads to endogenous stimulation of COX-2 which con-
sequently increases both CDK inhibitors studied after 24 h.
In contrast, Hannken et al. [13] have shown an induction of
p27kip1 by H2O2 in proximal tubular cells leading to hypertro-
phy of these cells. Furthermore, Macip et al. [20] have demon-
strated that p21cip1 increased intracellular ROS which induced
senescence in normal ﬁbroblasts and p53-negative cancer cells.
ROS inhibition rescued p21cip1 induced senescence. These dif-
ferences between our study where increased intracellular ROS
clearly mediate proliferation through downregulation of
p27kip1 as well as p21cip1 and the studies of Hannken and Ma-
cip could possibly be attributed to the use of diﬀerent cell
types. Furthermore, it could be possible that the increase of
intracellular ROS through exogenously administered ROS do-
nors downregulates p21cip1 in a negative feedback regulation
loop. No doubt, this discrepancy needs further clariﬁcation.
In conclusion, the data presented in the current study reveal
ROS as important mediators of MC proliferation. ROS seem
to function as competence factors which must be present at a
speciﬁc concentration in order to permit PDGF-induced cell
proliferation. COX-2 might therefore inﬂuence proliferation
of glomerular MC through controlling ROS levels. Since
ROS levels are increased in proliferative renal disease this
study underscores the role of ROS in controlling proliferative
events. Thus, modulation of the ROS levels in an early phase
of such disease might possibly exert beneﬁcial eﬀects on the
progression of renal diseases.
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